Bayer's Vividion Therapeutics unit has enrolled its first patient in a global Phase II study, the company said Friday, ...
The FINANCIAL — Bayer CropScience has opened a rice research laboratory in Singapore dedicated to support the development of new high-yielding hybrid rice varieties. Representing an investment of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AgStart and Bayer Crop Science ...
Bayer said its Crop Science division is on track with its five-year plan, including more than EUR 1 billion in cost savings and targets for EUR 3.5 billion in added revenue and EUR 1.5 billion in ...
Bayer fell after FMC's guidance cut, but JPMorgan and UBS reaffirmed bullish calls, and Vividion dosed its first patient in a Phase II trial. Bayers, Two-Speed, Story, Clinical, Wins, Lab, Sector, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results